Treatment cost for typhoid fever at two hospitals in Kolkata, India

Journal of Health, Population and Nutrition

Volumn 27, Issue 6, 2009, Pages 725-732

  Sur, Dipika ^a   Chatterjee, Susmita ^a   Riewpaiboon, Arthorn ^b   Manna, Byomkesh ^a   Kanungo, Suman ^a   Bhattacharya, Sujit K ^c  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^b MAHIDOL UNIVERSITY   (Thailand)

^c INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

Costs of illness; Healthcare cost; India; Treatment cost; Typhoid fever

Indexed keywords

ADULT; ARTICLE; CHILD; ECONOMICS; HEALTH CARE COST; HOSPITAL COST; HUMAN; INDIA; LENGTH OF STAY; TYPHOID FEVER;

ADULT; CHILD; HEALTH CARE COSTS; HOSPITAL COSTS; HUMANS; INDIA; LENGTH OF STAY; TYPHOID FEVER;

EID: 77449124948     PISSN: 16060997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hessel L, Debois H, Fletcher M, Dumas R. Experience with Salmonella typhi Vi capsular polysaccharide vaccine. Eur J Clin Microbiol Infect Dis 1999;18:609-20.
2. Acosta CJ, Galindo CM, Ochiai RL, Danovaro-Holliday MC, Page AL, Thiem VD et al. The role of epidemiology in the introduction of Vi polysaccharide typhoid fever vaccines in Asia. J Health Popul Nutr 2004;22:240-5.
3. Bahl R, Sinha A, Poulos C, Whittington D, Sazawal S, Kumar R et al. Costs of illness due to typhoid fever in an Indian urban slum community: implications for vaccination policy. J Health Popul Nutr 2004;22:304-10.
4. Poulos C, Bahl R, Whittington D, Bhan MK, Clemens JD, Acosta CJ. A cost-benefit analysis of typhoid fever immunization programmes in an Indian urban slum community. J Health Popul Nutr 2004;22:311-21.
5. Ochiai RL, Acosta CJ, Danovaro-Holliday MC, Bhattacharya SK, Agtini M et al. A study of typhoid fever in five Asian countries: disease burden and implications for control. Bull World Health Organ 2008;86:260-8.
6. Cook J, Jeuland M, Whittington D, Poulos C, Clemens J, Sur D et al. The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sitesin four Asian countries. Vaccine 2008;26:6305-16.
7. Pagano E, Brunetti M, Tediosi F, Garattini L. Costs of diabetes: a methodological analysis of the literature. Pharmacoeconomics 1999;15:583-95.
8. Brouwer W, Rutten F, Koopmanschap M. Costing in economic evaluations. In: Drummond M, McGuire A, editors. Economic evaluation in health care-merging theory with practice. New York, NY: Oxford University Press, 2001:68-93.
9. Riewpaiboon A, Malaroje S, Kongsawatt S. Effect of costing methods on unit cost of hospital medical services.Trop Med Int Health 2007;12:554-63.
10. Riewpaiboon A, Jaroenkitpan N, Wipaswacharayotin Y. Cost structure of hospital-based pharmaceutical services: a consideration of reimbursement. Mahidol Univ J Pharm Sci 2005;32:47-54.
11. Riewpaiboon A, Pornlertwadee P, Pongsawat K. Diabetes cost model of a hospital in Thailand. Value in Health 2007;10:223-30.
12. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press, 2005:55-101.
13. Finkler SA. The distinction between cost and charges. Ann Intern Med 1982;96:102-9.
14. Suver JD, Cooper JC. Principles and methods of managerial cost-accounting systems. Am J Hosp Phar 1988;45:146-52.
15. Mishra L, editor. Drug today; October-December 2004. Delhi: Larina Publications (India) Inc., 2004.
16. Canadian Coordinating Office for Health Technology Assessment. Guideline for economic evaluation of pharmaceuticals: Canada. 2nd ed. Ottawa: CCOHTA Publications, 1997:39-47.
17. Edejer TT-T, Baltussen R, Adam T, Hutubessy R, AcharyaA, Evans DB et al. Making choices in health: WHO guide to cost-effectiveness analysis. Geneva: World Health Organization, 2003:197-216.
18. Labour Bureau, Ministry of Labour and Employment, Chandigarh, India. (http://labourbureau.gov.in/CPI IW 2004, accessed on 22 October 2008).